Microstructure mapping with time-dependent diffusion MRI differentiates primary central nervous system lymphoma from glioblastoma.
Paper
Loaded from Europe PMC by your browser, not stored by OSCR: doi.org · Europe PMC
The paper is loaded when this pane is shown.
The authors' code
License · 21 lines · 1 KB · MIT
- MIT License
- Copyright (c) 2021 zjuzzl
- Permission is hereby granted, free of charge, to any person obtaining a copy
- of this software and associated documentation files (the "Software"), to deal
- in the Software without restriction, including without limitation the rights
- to use, copy, modify, merge, publish, distribute, sublicense, and/or sell
- copies of the Software, and to permit persons to whom the Software is
- furnished to do so, subject to the following conditions:
- The above copyright notice and this permission notice shall be included in all
- copies or substantial portions of the Software.
- THE SOFTWARE IS PROVIDED "AS IS", WITHOUT WARRANTY OF ANY KIND, EXPRESS OR
- IMPLIED, INCLUDING BUT NOT LIMITED TO THE WARRANTIES OF MERCHANTABILITY,
- FITNESS FOR A PARTICULAR PURPOSE AND NONINFRINGEMENT. IN NO EVENT SHALL THE
- AUTHORS OR COPYRIGHT HOLDERS BE LIABLE FOR ANY CLAIM, DAMAGES OR OTHER
- LIABILITY, WHETHER IN AN ACTION OF CONTRACT, TORT OR OTHERWISE, ARISING FROM,
- OUT OF OR IN CONNECTION WITH THE SOFTWARE OR THE USE OR OTHER DEALINGS IN THE
- SOFTWARE.
LICENSE at commit 35e78bc, under MIT · at the source
Overview
- Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022 China
- Hubei Provincial Clinical Research Center for Precision Radiology & Interventional Medicine, Wuhan, 430022 China
- Hubei Province Key Laboratory of Molecular Imaging, Wuhan, 430022 China
- MSC Clinical & Technical Solutions, Philips Healthcare, Wuhan, China
- Institute of Research and Clinical Innovations, Neusoft Medical Systems Co. Ltd, Shenyang, 110167 China
Abstract
The abstract is not reproduced here: the paper's license (CC BY-NC-ND) does not allow it. Read it in the paper, at the publisher or on Europe PMC.
Repository
Its files are read in the Code ↔ Paper reader above.
zjuzzl/prostate_mri
35e78bc60497f38002f1754c096f9af2710653cf, 25 July 2021Availability: 1 check, the latest on 27 September 2026: the link answers
- 27 September 2026: the link answers
Tracing map
Proposed by the machine: these links were found in the paper and verified at the source, without human review. The map will receive a Zenodo DOI once one of the paper's authors has validated it with their ORCID.
What the map holds:
- 1 repository of the authors' code, each at its verified commit, with its license and how the link was found in the paper;
- 0 scripts, each with its path and the digest of its content;
- no match between paragraphs and code yet;
- neither the text of the paper nor the code itself.
Its JSON (tracing-map.json) is deposited on Zenodo with its DOI once the map is validated.
Data
No dataset and no data link were found in the paper.
Data availability statement
The paper has a data availability statement. Its license (CC BY-NC-ND) does not allow reproducing it here; in short, from what the harvester recognized in it:
- it says that the data are available on request
Read it in the paper: doi.org/10.1186/s40644-026-01052-6.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 27 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 10 authors, 4 keywords, 12 MeSH terms, 44 references.
Cite
This paper
Wu, J., Lu, J., Zhang, X., Guo, X., Qin, Q., Chen, J., Zheng, N., Sun, P., Gao, X., & Wang, J. (2026). Microstructure mapping with time-dependent diffusion MRI differentiates primary central nervous system lymphoma from glioblastoma. Cancer imaging : the official publication of the International Cancer Imaging Society, 26(1), 78. https://
BibTeX
@article{wu2026microstru
author = {Wu, Jun and Lu, Jue and Zhang, Xinli and Guo, Xiaotong and Qin, Qian and Chen, Jiaqi and Zheng, Ning and Sun, Peng and Gao, Xuan and Wang, Jing},
title = {{Microstructure mapping with time-dependent diffusion MRI differentiates primary central nervous system lymphoma from glioblastoma}},
journal = {Cancer imaging : the official publication of the International Cancer Imaging Society},
year = {2026},
month = jun,
volume = {26},
number = {1},
pages = {78},
publisher = {BMC},
issn = {1740-5025},
doi = {10.1186/
url = {https://
pmid = {42226306},
pmcid = {PMC13270852}
}
RIS
TY - JOUR
AU - Wu, Jun
AU - Lu, Jue
AU - Zhang, Xinli
AU - Guo, Xiaotong
AU - Qin, Qian
AU - Chen, Jiaqi
AU - Zheng, Ning
AU - Sun, Peng
AU - Gao, Xuan
AU - Wang, Jing
TI - Microstructure mapping with time-dependent diffusion MRI differentiates primary central nervous system lymphoma from glioblastoma
T2 - Cancer imaging : the official publication of the International Cancer Imaging Society
J2 - Cancer Imaging
PY - 2026
DA - 2026/
VL - 26
IS - 1
SP - 78
SN - 1740-5025
PB - BMC
DO - 10.1186/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.1186/
"type": "article-journal",
"title": "Microstructure mapping with time-dependent diffusion MRI differentiates primary central nervous system lymphoma from glioblastoma",
"container-title": "Cancer imaging : the official publication of the International Cancer Imaging Society",
"author": [
{
"family": "Wu",
"given": "Jun"
},
{
"family": "Lu",
"given": "Jue"
},
{
"family": "Zhang",
"given": "Xinli"
},
{
"family": "Guo",
"given": "Xiaotong"
},
{
"family": "Qin",
"given": "Qian"
},
{
"family": "Chen",
"given": "Jiaqi"
},
{
"family": "Zheng",
"given": "Ning"
},
{
"family": "Sun",
"given": "Peng"
},
{
"family": "Gao",
"given": "Xuan"
},
{
"family": "Wang",
"given": "Jing"
}
],
"container-title-short":
"volume": "26",
"issue": "1",
"page": "78",
"DOI": "10.1186/
"PMID": "42226306",
"PMCID": "PMC13270852",
"ISSN": "1740-5025",
"publisher": "BMC",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
6,
1
]
]
}
}
The tracing map gets a citation of its own once an author has validated it and it has a DOI.
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1016/j.isci.2026.117281 [code]
- Spatial pattern-driven interpretable model and biological correlates in brain glioblastoma-lymphoma differentiation.Journal: iScienceIn common: other condition, 4 references
- [2] doi:10.1158/2767-9764.crc-25-0710 [code]
- MRI Deep Learning for Differentiating Glioblastoma, IDH Wild-type from Central Nervous System Diffuse Large B-cell Lymphoma.Journal: Cancer research communicationsIn common: structural MRI / diffusion, clinical / translational, other condition, 3 references
- [3] doi:10.1186/s12880-026-02434-9 [code]
- Exploring the value of peritumoral brain zone for classification of two malignant brain tumors based on the MRI interpretable models.Journal: BMC medical imagingIn common: structural MRI / diffusion, clinical / translational, other condition, 3 references
- [4] doi:10.1007/s12672-026-04980-8
- PARP4 drives tumor progression by promoting glioma cell proliferation and invasion as a potential therapeutic target.Journal: Discover oncologyIn common: clinical / translational, other condition, 3 references
- [5] doi:10.1016/j.isci.2026.117476
- Integrated 3D light sheet and 2D multiplex imaging for deep histological characterization of somatic mouse glioblastoma.Journal: iScienceIn common: histology / microscopy, other condition, 2 references
- [6] doi:10.1007/s11060-026-05635-y
- From relapse to survival: real-world clinical impact of a multimodal approach in first-time recurrent glioblastoma : FROST: multimodal treatment for GBM recurrence.Journal: Journal of neuro-oncologyIn common: clinical / translational, other condition, 2 references
- [7] doi:10.3390/ijms27167240
- 1-Piperidine Propionic Acid Inhibits PAR2/
SerpinB3 Signaling and Reduces Glioblastoma Tumor Aggressiveness. Journal: International journal of molecular sciencesIn common: other condition, 2 references - [8] doi:10.1016/j.omton.2026.201201
- Enable CAR T cell immunotherapy in glioblastoma by modifying its microenvironment via oncolytic adenovirus encoding bispecific T cell engager.Journal: Molecular therapy. OncologyIn common: other condition, 2 references
- [9] doi:10.1038/s41698-026-01475-1 [code]
- Radiomics model integrating MRI and ECV enhances prediction accuracy for progression in high-grade glioma.Journal: NPJ precision oncologyIn common: structural MRI / diffusion, clinical / translational, other condition, 1 reference
- [10] doi:10.1371/journal.pone.0356382 [code]
- Evaluating the impact of segmentation strategies on radiomic feature stability for paediatric brain tumour diagnosis using diffusion weighted imaging.Journal: PloS oneIn common: structural MRI / diffusion, clinical / translational, other condition, 1 reference
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Validate its tracing map
You validate the map as this page shows it: 1 repository of the authors' code, each at its verified commit and with its license, 0 scripts, and 0 matches between paragraphs and code (see the Code and Map sections). It then receives a DOI on Zenodo, with you (your ORCID iD) and OSCR as its creators; the code itself is not deposited.
The map's fingerprint: sha256:87628f61376c7376…
Add the badge to its README
The badge links the code to this page. Copy one of these into the README of the paper's code: only you decide where it goes, and nothing is changed for you.
Markdown
[, paste the snippet at the top, then “Commit changes…” and, to review it first, “Create a new branch and start a pull request”. You open the pull request; OSCR asks for no permission.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.
Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
